Zai Lab (ZLAB) Current Leases (2019 - 2026)
Zai Lab (ZLAB) posted quarterly Current Leases of $6.0 million for Q1 2026, down 8.99% year-on-year from $6.6 million in Q1 2025, and down 5.69% on a QoQ basis from $6.3 million in Q4 2025.
Zai Lab (ZLAB) Current Leases (2019 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Current Leases for 8 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.
- Quarterly Current Leases fell 8.99% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 8.99% YoY) and the FY2025 annual result came in at $6.3 million, down 21.17% from the prior year.
- Current Leases eased to $6.0 million in Q1 2026 per ZLAB's latest filing, from $6.3 million in the prior quarter.
- Over the last five years, Current Leases for ZLAB reached as high as $8.0 million in Q4 2024 and fell as low as $5.5 million in Q3 2025.
- A 5-year average of $6.8 million and a median of $6.9 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases advanced 21.3% — and 2025, when it dropped 26.34%.
- Year by year, Current Leases stood at $7.0 million in 2022, then grew by 0.77% to $7.1 million in 2023, then rose by 13.29% to $8.0 million in 2024, then dropped by 21.17% to $6.3 million in 2025, then dropped by 5.69% to $6.0 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $6.0 million, $6.3 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 5.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.98 Mn |
| Dec 31, 2025 | 6.34 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 6.57 Mn |
| Dec 31, 2024 | 8.05 Mn |
| Sep 30, 2024 | 6.59 Mn |
| Jun 30, 2024 | 7.58 Mn |
| Mar 31, 2024 | 7.54 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 6.89 Mn |
| Jun 30, 2023 | 7.30 Mn |
| Mar 31, 2023 | 7.32 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 6.98 Mn |
| Jun 30, 2022 | 6.82 Mn |
| Mar 31, 2022 | 6.80 Mn |
| Dec 31, 2021 | 5.93 Mn |
| Sep 30, 2021 | 6.31 Mn |
| Jun 30, 2021 | 6.37 Mn |